Cargando…
Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Heart and Lung Transplantation.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162760/ https://www.ncbi.nlm.nih.gov/pubmed/32360293 http://dx.doi.org/10.1016/j.healun.2020.04.007 |
_version_ | 1783523086008582144 |
---|---|
author | Badagliacca, Roberto Sciomer, Susanna Petrosillo, Nicola |
author_facet | Badagliacca, Roberto Sciomer, Susanna Petrosillo, Nicola |
author_sort | Badagliacca, Roberto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7162760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Society for Heart and Lung Transplantation. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71627602020-04-17 Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? Badagliacca, Roberto Sciomer, Susanna Petrosillo, Nicola J Heart Lung Transplant Article International Society for Heart and Lung Transplantation. 2020-07 2020-04-17 /pmc/articles/PMC7162760/ /pubmed/32360293 http://dx.doi.org/10.1016/j.healun.2020.04.007 Text en © 2020 International Society for Heart and Lung Transplantation. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Badagliacca, Roberto Sciomer, Susanna Petrosillo, Nicola Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title_full | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title_fullStr | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title_full_unstemmed | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title_short | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? |
title_sort | endothelin receptor antagonists for pulmonary arterial hypertension and covid-19: friend or foe? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162760/ https://www.ncbi.nlm.nih.gov/pubmed/32360293 http://dx.doi.org/10.1016/j.healun.2020.04.007 |
work_keys_str_mv | AT badagliaccaroberto endothelinreceptorantagonistsforpulmonaryarterialhypertensionandcovid19friendorfoe AT sciomersusanna endothelinreceptorantagonistsforpulmonaryarterialhypertensionandcovid19friendorfoe AT petrosillonicola endothelinreceptorantagonistsforpulmonaryarterialhypertensionandcovid19friendorfoe |